HomeTagsSNIPR001

SNIPR001

Biotechnology

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

PR Newswire - April 21, 2022

SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, announced dosing of the first human subjects in its phase 1 clinical...

Biotechnology

FDA Clears SNIPR BIOME’s Investigational New Drug Application for SNIPR001, Targeting E. coli Infections

PR Newswire - January 11, 2022

SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is pleased to announce that the US Food and Drug Administration (FDA) has approved...